|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Clin Cancer Res. 10(1 Pt 1):155-65 |
Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib. |
McLean LA, Gathmann I, Capdeville R, Polymeropoulos MH, Dressman M.
Clinical Pharmacogenetics Department, Novartis Pharmaceuticals Corporation, Gaithersburg, Maryland, USA. leanne.mclean@pharma.novartis.com |
Publication Date: Wednesday, January 21, 2004
|
Click here to view MEDLINE citation |
|
More January, 2004 pharmacogenomics journal articles.- Cancer pharmacogenetics: polymorphisms, pathways and beyond.
by Ulrich CM, Robien K, McLeod HL.
Journal: Nat Rev Cancer. 3(12):912-20
- Cancer pharmacogenetics.
by Marsh S, McLeod HL.
Journal: Br J Cancer. 90(1):8-11
- Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
by Jørgensen LB, Christensen MB, Gerstoft J, Mathiesen LR, Obel N, Pedersen C, Nielsen H, Nielsen C.
Journal: Scand J Infect Dis. 35(11-12):800-7
- Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways.
by Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C.
Journal: Nat Biotechnol. 12 2003;22(1):62-9
- The biological magic behind the bullets.
by Stockwell BR.
Journal: Nat Biotechnol. 22(1):37-8
- Development of analytical technology in pharmacogenetic research.
by Daly AK.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 09 2003;369(1):133-40
- In a hurry to slow life's clock.
by Boyce N.
Journal: US News World Rep. 2003 Dec 29-2004 Jan 5;135(23):74-5
- FDA seeks genome-based drug data.
by Hampton T.
Journal: JAMA. 291(1):32-3
- Watson and Crick 50 years on. From double helix to pharmacogenomics.
by Sweeney BP.
Journal: Anaesthesia. 59(2):150-65
- "Cocktail" approaches and strategies in drug development: valuable tool or flawed science?
by Zhou H, Tong Z, McLeod JF.
Journal: J Clin Pharmacol. 44(2):120-34
- Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
by Morley KI, Hall WD.
Journal: J Mol Med. 11 2003;82(1):21-30
- Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD).
by Mattingly CJ, Colby GT, Rosenstein MC, Forrest JN, Boyer JL.
Journal: Pharmacogenomics J. 4(1):5-8
- [Pharmacology in epilepsy. Where are we heading for?]
by Herranz JL.
Journal: Rev Neurol. 2004 Jan 16-31;38(2):167-72
- Cancer trials get set for biomarkers.
by Bouchie A.
Journal: Nat Biotechnol. 22(1):6-7
- A step past chemotherapy.
by Kalb C.
Journal: Newsweek. 142(23):73-4
- Pharmacogenetics of soluble sulfotransferases (SULTs).
by Glatt H, Meinl W.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 11 2003;369(1):55-68
- Protecting communities in pharmacogenetic and pharmacogenomic research.
by Weijer C, Miller PB.
Journal: Pharmacogenomics J. 4(1):9-16
- Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
by Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ.
Journal: Toxicol Sci. 11 2003;77(1):19-34
- Pharmacogenomics in psychiatry.
by
Journal: Harv Ment Health Lett. 20(7):4-5
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|